Dog Dewormers Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The global dog dewormers market size was valued at around USD 1.4 billion in 2023 and is estimated to grow at a 9.5% CAGR from 2024 to 2032. The global concern for zoonotic diseases and an increase in pets are the factors influencing the growth of the market.
COVID-19 fostered pet adoption owing to pet owners' lifestyle changes and urbanization, especially in developed nations. For instance, as the American Pet Products Association cited, 66% of the US Population owned pets in 2023. Moreover, in 2022, pet spending particularly with regards to veterinary services increased to USD 35.9 billion. All of this cumulatively drives up demand for dog dewormers in the country. Pet owners value prevention when it comes to their pets' health.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Dog Dewormers Market size in 2023: | USD 1.4 Billion |
Forecast Period: | 2024 – 2032 |
Forecast Period 2023 - 2032 CAGR: | 9.5 |
2023 Value Projection: | USD 3.1 Billion |
Historical Data for: | 2021 – 2023 |
No of Pages: | 100 |
Tables, Charts & Figures: | 152 |
Segments Covered: | Product Type, Distribution Channel, and Region |
Growth Drivers: |
|
Pitfalls Challenges: |
|
There is also an intensification of focus on diseases that can be passed on from pets to humans. Pets that carry a high risk of infection from parasitic bugs can pose invasive health risks to people. Many pet owners and veterinarians are now more cognizant of the measures that can prevent such diseases. As worms, especially roundworms and hookworms, can spread from dogs to humans, there is an increased focus on regular deworming which, in turn, has led to increased sales of dog dewormers.
Moreover, medications used to expel parasitic worms in dogs, such as roundworms, hookworms, tapeworms, and whipworms, are known as dog dewormers, and they fall under veterinary medications. Such treatments also help mitigate the health problems that these parasites could cause for dogs and also help decrease the zoonotic diseases that can be transferred to humans.
There are rising technologies being adopted for dog dewormers, it is gradually carving out its place in the market. Such advancing technologies focus on making the medicines safer and more effective, which, in turn, makes it easier for more pet owners to adopt regular deworming practices.
Based on product type, the market is classified into tablets and chewable treats, topical solutions, and injections. The tablets and chewable treats segment generated the highest revenue of USD 768.6 million in 2023.
Based on the distribution channel, the dog dewormers market is classified into veterinary clinics, retail pharmacies, online platforms, and pet stores. The veterinary clinics segment generated the highest revenue of USD 560.2 million in 2023.
North America's dog dewormers market accounted for USD 513.3 million in revenue in 2023 and is anticipated to grow at a CAGR of 9.1% between the 2024–2032 period.
The U.S. held a dominant position in the dog dewormers market, with revenue of USD 473.5 million in 2023.
The UK dog dewormers market is anticipated to witness substantial growth from 2024 to 2032.
Japan holds a dominant position in the Asia Pacific dog dewormers market.
The market for dog dewormers is fragmented, populated by a myriad of multi-national corporations and mid-sized and small firms competing for market share. The expansion and growth of companies in this segment revolves around developing and introducing new efficient and economical deworming remedies.
This innovative approach fuels competition and developments within the market as firms attempt to meet changing clinical requirements and pet health needs. Companies strive to increase their market capture by novel formulations and delivery systems in order to meet the growing sophistication of dog deworming needs.
Some of the eminent market participants operating in the dog dewormers industry include:
Market, By Product Type
By Distribution Channel
The above information is provided for the following regions and countries:
Some of the prominent market participants include Bayer AG, Beaphar, Bimeda, Inc., Boehringer Ingelheim International GmbH, Ceva Sant
In 2023, North America's market recorded USD 513.3 million in revenue and is anticipated to grow at a CAGR of 9.1% between 2024 and 2032. The high pet ownership rates in the U.S. and Canada drive this demand, as owners seek to keep their pets free from parasites.
The industry was valued at approximately USD 1.4 billion in 2023 and is projected to grow at a 9.5% CAGR from 2024 to 2032, driven by increased pet ownership and a rising focus on zoonotic diseases.
Tablets and chewable treats generated the highest revenue of USD 768.6 million in 2023. Their popularity stems from their convenience, ease of administration, and high compliance rates among pet owners.